Navidea Biopharmaceuticals Inc (NYSE MKT LLC:NAVB)

1.68
Delayed Data
As of Jul 02
 +0.06 / +3.70%
Today’s Change
0.97
Today|||52-Week Range
2.02
-11.11%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues597.7K78.7K1.1M6.3M
 
 
 
 
 
Cost of Goods Sold----332.8K1.6M
 
 
 
Depreciation And Amortization176.5K200.2K404.2K500.2K
 
 
 
 
 
 
Operating ExpensesGross Income----393.6K4.2M
 
 
 
General Expenses24.5M27.9M38.8M31.2M
 
 
 
 
 
Research And Development15.2M16.9M23.7M16.8M
 
 
 
 
 
Total Operating Expenses24.7M28.1M39.6M33.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-24.1M-28.0M-38.4M-27.0M
 
 
 
 
 
Extraordinary Credit0.0032.1K0.00--
 
 
Extraordinary Charge-952.4K---1.5M-4.6M
 
 
 
 
Pre-Tax Equity Earnings0.00--0.00-523.8K
 
 
Interest Expense On Debt13.3K1.2M2.8M3.7M
 
 
 
 
 
Other Expenses-3.2K-58.7K-16.9K72.7K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-25.0M-29.2M-42.7M-35.7M
 
 
 
 
 
Income Taxes-7.9M0.000.000.00
 
 
Preferred Dividend-100.0K-43.3K0.000.00
 
 
 
Discontinued Operations3.3M0.000.000.00
 
 
Extraordinary Items19.5M0.000.000.00
 
 
Net Income-13.8M-29.2M-42.7M-35.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS90.5M99.1M121.8M148.7M
 
 
 
 
 
Shares To Calculate EPS Diluted90.5M99.1M121.8M148.7M
 
 
 
 
 
 
Earnings Per ShareEPS$0.06-$0.29-$0.35-$0.24
 
 
 
 
 
EPS Diluted-$0.15-$0.29-$0.35-$0.24
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account